Ann Dermatol.  2023 May;35(Suppl1):S71-S75. 10.5021/ad.20.207.

Insulin-Derived Cutaneous Amyloidosis: A Possible Complication of Repeated Insulin Injections

• Park HJ
• Kim WS
• Chae SW
• Choi YJ

• KMID: 2542744
• DOI: http://doi.org/10.5021/ad.20.207

Abstract

Primary localized cutaneous amyloidosis (PLCA) is characterized by extracellular deposition of pathological fibril aggregation of proteins in the skin without systemic involvement. Macular amyloidosis, lichen (papular) amyloidosis, and nodular amyloidosis are three different subtypes of PLCA. Although the pathological mechanism of PLCA has not yet been clarified, it is assumed that a nucleus formation of amyloid fibril is formed due to repeated external stimulation, such as subcutaneous injection, which often poses diagnostic challenges. Herein, we present a 54-year-old Korean male patient with cutaneous localized amyloidosis which occurred after repeated local insulin injections, and discuss the relationship between insulin therapy in patients with diabetes mellitus and dermal amyloid deposition.

Keyword

Amyloidosis; Diabetes mellitus; Insulin; Subcutaneous injections